+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Single Cancer Screening Market - Global Forecast 2025-2030- Product Image
Single Cancer Screening Market - Global Forecast 2025-2030- Product Image
Sale

Single Cancer Screening Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6131264
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The single cancer screening market is undergoing a pivotal transformation, driven by rapid advances in diagnostic technology and heightened focus on early detection. Senior executives face a landscape where innovation, regulatory changes, and evolving clinical pathways create new opportunities and challenges for screening platform adoption and market growth.

Market Snapshot: Single Cancer Screening Market Overview

The single cancer screening sector is reshaping how oncology diagnostics are deployed, powered by significant advances in molecular diagnostics, imaging techniques, and artificial intelligence. With increasing patient awareness and the push for preventive care, healthcare systems are prioritizing cost-effective and accessible screening solutions. As stakeholders invest in next-generation platforms, shifting policy frameworks and global supply chain recalibrations play a critical role in shaping commercial strategies.

Scope & Segmentation of the Single Cancer Screening Market

This comprehensive research report covers a detailed segmentation of the single cancer screening market, equipping decision-makers with actionable perspectives on emerging growth avenues:

  • Cancer Type: Breast (AI tools, imaging including mammography, MRI, ultrasound, molecular tests, liquid biopsy, tissue assays), Cervical (imaging, molecular tests), Colorectal (endoscopy, capsule endoscopy, colonoscopy, imaging CT, MRI, molecular blood-based and stool-based), Lung (imaging, molecular tests), Prostate (imaging, molecular tests), Skin (imaging, molecular tests)
  • Technology: AI-based predictive analytics, software algorithms, endoscopy, capsule endoscopy, colonoscopy, genomic sequencing, PCR-based assays, imaging (CT, mammography, MRI, PET, ultrasound), molecular tests (liquid biopsy, tissue-based assays)
  • End User: Academic research institutes, diagnostic centers, independent labs, lab chains, home care providers, hospitals (private, public), specialty clinics
  • Screening Method: Invasive (endoscopic procedures, tissue biopsy), minimally invasive (capsule endoscopy), non-invasive (imaging, liquid biopsy)
  • Distribution Channel: Direct sales, online channels, third-party distributors
  • Geographic Regions: Americas (including United States – California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio – Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Major Market Players: F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Hologic, Inc., QIAGEN N.V., Myriad Genetics, Inc., Exact Sciences Corporation, Becton Dickinson and Company

Key Takeaways for Senior Decision-Makers

  • Rapid convergence of AI-driven analytics, molecular diagnostics, and imaging is fundamentally realigning cancer screening approaches for quicker and more personalized detection.
  • Patient-centric innovations like at-home sampling kits and digital telehealth platforms are increasing accessibility while strengthening adherence and reducing barriers to participation.
  • Supply chain resilience now underpins business continuity as manufacturers pursue near-shoring and diversification, particularly in response to new tariff frameworks and regional regulation.
  • Strategic alliances, mergers, and partnerships are transforming vendor landscapes, enabling bundled solutions and stronger clinical validation pipelines.
  • Regional dynamics highlight differentiated adoption patterns; established regions invest in integrated workflows, while high-growth markets in Asia-Pacific gain from government-backed screening campaigns and cross-border innovation exchange.
  • Technology leadership, validated clinical outcomes, and real-world data integration are key success factors for sustained market advancement.

Assessing Tariff Impact on the Single Cancer Screening Market

The 2025 United States tariffs on imported diagnostics, imaging components, and molecular testing equipment have introduced cost pressures across the single cancer screening supply chain. Firms are revising sourcing strategies through domestic production, while also navigating new complexities in quality control and logistics. Balancing compliance with changing import classifications and regulatory pathways, these cost adjustments are directly influencing budget allocations and competitive strategy throughout key buyer segments such as hospitals, diagnostic centers, and specialty clinics.

Methodology & Data Sources

This report uses a rigorous mixed-method approach, integrating primary interviews with global experts and extensive review of peer-reviewed journals, regulatory filings, and industry white papers. Cross-validation and triangulation ensure credible segmentation analysis and robust market projections.

Why This Report Matters

  • Enables C-suite leaders to anticipate strategic inflection points, navigate tariff developments, and respond to disruptive regulatory trends with confidence.
  • Delivers a granular breakdown of segmentation, regional outlooks, and competitive moves, providing a data-driven basis for investment, partnership, and deployment strategies.
  • Guides actionable decision-making by presenting validated insights that link evolving patient needs, technology adoption, and emerging business models.

Conclusion

As the single cancer screening landscape continues to evolve, collaboration, innovation, and patient-centric design will define market leadership. Senior stakeholders equipped with current insights and strategic guidance can drive adoption and optimize clinical and operational outcomes.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of multi-cancer early detection blood tests using cfDNA methylation analysis in asymptomatic adults
5.2. Integration of artificial intelligence algorithms with radiology imaging to improve early tumor detection accuracy in breast cancer screening
5.3. Expansion of at-home self-collection kits for colorectal cancer screening improving patient compliance and access in underserved areas
5.4. Strategic collaborations between diagnostic companies and telehealth platforms to enable remote patient screening and follow-up support
5.5. Regulatory advancements and expedited FDA pathways for next generation sequencing based single cancer screening assays
5.6. Growing reimbursement coverage for liquid biopsy tests driving market uptake among healthcare providers and payers
5.7. Development of single-use point-of-care molecular diagnostics reducing time to detection in oncology screening settings
5.8. Emerging use of circulating tumor cell isolation technologies enhancing specificity for early detection of solid tumors in screening programs
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Single Cancer Screening Market, by Cancer Type
8.1. Introduction
8.2. Breast
8.2.1. AI Based Tools
8.2.2. Imaging
8.2.2.1. Mammography
8.2.2.2. MRI
8.2.2.3. Ultrasound
8.2.3. Molecular Tests
8.2.3.1. Liquid Biopsy
8.2.3.2. Tissue Based Assays
8.3. Cervical
8.3.1. Imaging
8.3.2. Molecular Tests
8.4. Colorectal
8.4.1. Endoscopy
8.4.1.1. Capsule Endoscopy
8.4.1.2. Colonoscopy
8.4.2. Imaging
8.4.2.1. CT
8.4.2.2. MRI
8.4.3. Molecular Tests
8.4.3.1. Blood Based
8.4.3.2. Stool Based
8.5. Lung
8.5.1. Imaging
8.5.2. Molecular Tests
8.6. Prostate
8.6.1. Imaging
8.6.2. Molecular Tests
8.7. Skin
8.7.1. Imaging
8.7.2. Molecular Tests
9. Single Cancer Screening Market, by Technology
9.1. Introduction
9.2. AI Based Tools
9.2.1. Predictive Analytics
9.2.2. Software Algorithms
9.3. Endoscopy
9.3.1. Capsule Endoscopy
9.3.2. Colonoscopy
9.4. Genomic
9.4.1. Next Generation Sequencing
9.4.2. PCR Based Assays
9.5. Imaging
9.5.1. CT
9.5.2. Mammography
9.5.3. MRI
9.5.4. PET
9.5.5. Ultrasound
9.6. Molecular Tests
9.6.1. Liquid Biopsy
9.6.2. Tissue Based Assays
10. Single Cancer Screening Market, by End User
10.1. Introduction
10.2. Academic Research Institutes
10.3. Diagnostic Centers
10.3.1. Independent Labs
10.3.2. Lab Chains
10.4. Home Care Providers
10.5. Hospitals
10.5.1. Private Hospitals
10.5.2. Public Hospitals
10.6. Specialty Clinics
11. Single Cancer Screening Market, by Screening Method
11.1. Introduction
11.2. Invasive
11.2.1. Endoscopic Procedures
11.2.2. Tissue Biopsy
11.3. Minimally Invasive
11.3.1. Capsule Endoscopy
11.4. Non Invasive
11.4.1. Imaging Based
11.4.2. Liquid Biopsy
12. Single Cancer Screening Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Online Channels
12.4. Third Party Distributors
13. Americas Single Cancer Screening Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Single Cancer Screening Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Single Cancer Screening Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd
16.3.2. Thermo Fisher Scientific Inc.
16.3.3. Abbott Laboratories
16.3.4. Siemens Healthineers AG
16.3.5. Danaher Corporation
16.3.6. Hologic, Inc.
16.3.7. QIAGEN N.V.
16.3.8. Myriad Genetics, Inc.
16.3.9. Exact Sciences Corporation
16.3.10. Becton Dickinson and Company
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. SINGLE CANCER SCREENING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY SCREENING METHOD, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY SCREENING METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SINGLE CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SINGLE CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SINGLE CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SINGLE CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. SINGLE CANCER SCREENING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. SINGLE CANCER SCREENING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. SINGLE CANCER SCREENING MARKET: RESEARCHAI
FIGURE 26. SINGLE CANCER SCREENING MARKET: RESEARCHSTATISTICS
FIGURE 27. SINGLE CANCER SCREENING MARKET: RESEARCHCONTACTS
FIGURE 28. SINGLE CANCER SCREENING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. SINGLE CANCER SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY BREAST, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY BREAST, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY AI BASED TOOLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY AI BASED TOOLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MRI, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY TISSUE BASED ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY TISSUE BASED ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY BREAST, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY BREAST, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY CERVICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY CERVICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY CERVICAL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY CERVICAL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY COLORECTAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY COLORECTAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY ENDOSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY COLONOSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY COLONOSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY ENDOSCOPY, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY CT, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY CT, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MRI, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY BLOOD BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY BLOOD BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY STOOL BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY STOOL BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY COLORECTAL, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY COLORECTAL, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY LUNG, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY LUNG, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY LUNG, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY LUNG, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY PROSTATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY PROSTATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY PROSTATE, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY PROSTATE, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY SKIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY SKIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY SKIN, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY SKIN, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY AI BASED TOOLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY AI BASED TOOLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY PREDICTIVE ANALYTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY PREDICTIVE ANALYTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY SOFTWARE ALGORITHMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY SOFTWARE ALGORITHMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY AI BASED TOOLS, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY AI BASED TOOLS, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY ENDOSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY COLONOSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY COLONOSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY ENDOSCOPY, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY GENOMIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY GENOMIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY PCR BASED ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY PCR BASED ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY GENOMIC, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY GENOMIC, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY CT, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY CT, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MRI, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY PET, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY PET, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY TISSUE BASED ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY TISSUE BASED ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY LAB CHAINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY LAB CHAINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY HOME CARE PROVIDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY HOME CARE PROVIDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 165. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 166. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 167. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY SCREENING METHOD, 2018-2024 (USD MILLION)
TABLE 168. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY SCREENING METHOD, 2025-2030 (USD MILLION)
TABLE 169. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 170. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY INVASIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 171. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY ENDOSCOPIC PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 172. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY ENDOSCOPIC PROCEDURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 173. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 174. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 175. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
TABLE 176. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY INVASIVE, 2025-2030 (USD MILLION)
TABLE 177. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 178. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 179. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 180. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 181. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
TABLE 182. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2030 (USD MILLION)
TABLE 183. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY NON INVASIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 184. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY NON INVASIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 185. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 186. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 187. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 188. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 189. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY NON INVASIVE, 2018-2024 (USD MILLION)
TABLE 190. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY NON INVASIVE, 2025-2030 (USD MILLION)
TABLE 191. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 194. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 195. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 196. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 197. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 198. GLOBAL SINGLE CANCER SCREENING MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY BREAST, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY BREAST, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 207. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY CERVICAL, 2018-2024 (USD MILLION)
TABLE 208. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY CERVICAL, 2025-2030 (USD MILLION)
TABLE 209. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY COLORECTAL, 2018-2024 (USD MILLION)
TABLE 210. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY COLORECTAL, 2025-2030 (USD MILLION)
TABLE 211. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
TABLE 212. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY ENDOSCOPY, 2025-2030 (USD MILLION)
TABLE 213. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 214. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 215. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 216. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 217. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY LUNG, 2018-2024 (USD MILLION)
TABLE 218. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY LUNG, 2025-2030 (USD MILLION)
TABLE 219. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY PROSTATE, 2018-2024 (USD MILLION)
TABLE 220. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY PROSTATE, 2025-2030 (USD MILLION)
TABLE 221. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY SKIN, 2018-2024 (USD MILLION)
TABLE 222. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY SKIN, 2025-2030 (USD MILLION)
TABLE 223. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 224. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 225. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY AI BASED TOOLS, 2018-2024 (USD MILLION)
TABLE 226. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY AI BASED TOOLS, 2025-2030 (USD MILLION)
TABLE 227. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
TABLE 228. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY ENDOSCOPY, 2025-2030 (USD MILLION)
TABLE 229. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY GENOMIC, 2018-2024 (USD MILLION)
TABLE 230. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY GENOMIC, 2025-2030 (USD MILLION)
TABLE 231. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 232. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 233. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 234. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 235. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 238. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 239. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 240. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 241. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY SCREENING METHOD, 2018-2024 (USD MILLION)
TABLE 242. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY SCREENING METHOD, 2025-2030 (USD MILLION)
TABLE 243. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
TABLE 244. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY INVASIVE, 2025-2030 (USD MILLION)
TABLE 245. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
TABLE 246. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2030 (USD MILLION)
TABLE 247. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY NON INVASIVE, 2018-2024 (USD MILLION)
TABLE 248. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY NON INVASIVE, 2025-2030 (USD MILLION)
TABLE 249. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 252. AMERICAS SINGLE CANCER SCREENING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 253. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 254. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 255. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY BREAST, 2018-2024 (USD MILLION)
TABLE 256. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY BREAST, 2025-2030 (USD MILLION)
TABLE 257. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 258. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 259. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 260. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 261. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY CERVICAL, 2018-2024 (USD MILLION)
TABLE 262. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY CERVICAL, 2025-2030 (USD MILLION)
TABLE 263. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY COLORECTAL, 2018-2024 (USD MILLION)
TABLE 264. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY COLORECTAL, 2025-2030 (USD MILLION)
TABLE 265. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
TABLE 266. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY ENDOSCOPY, 2025-2030 (USD MILLION)
TABLE 267. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 268. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 269. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 270. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 271. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY LUNG, 2018-2024 (USD MILLION)
TABLE 272. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY LUNG, 2025-2030 (USD MILLION)
TABLE 273. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY PROSTATE, 2018-2024 (USD MILLION)
TABLE 274. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY PROSTATE, 2025-2030 (USD MILLION)
TABLE 275. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY SKIN, 2018-2024 (USD MILLION)
TABLE 276. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY SKIN, 2025-2030 (USD MILLION)
TABLE 277. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 278. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 279. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY AI BASED TOOLS, 2018-2024 (USD MILLION)
TABLE 280. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY AI BASED TOOLS, 2025-2030 (USD MILLION)
TABLE 281. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
TABLE 282. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY ENDOSCOPY, 2025-2030 (USD MILLION)
TABLE 283. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY GENOMIC, 2018-2024 (USD MILLION)
TABLE 284. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY GENOMIC, 2025-2030 (USD MILLION)
TABLE 285. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 286. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 287. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 288. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 289. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 292. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 293. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 294. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 295. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY SCREENING METHOD, 2018-2024 (USD MILLION)
TABLE 296. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY SCREENING METHOD, 2025-2030 (USD MILLION)
TABLE 297. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
TABLE 298. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY INVASIVE, 2025-2030 (USD MILLION)
TABLE 299. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
TABLE 300. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2030 (USD MILLION)
TABLE 301. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY NON INVASIVE, 2018-2024 (USD MILLION)
TABLE 302. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY NON INVASIVE, 2025-2030 (USD MILLION)
TABLE 303. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 306. UNITED STATES SINGLE CANCER SCREENING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 307. CANADA SINGLE CANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 308. CANADA SINGLE CANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 309. CANADA SINGLE CANCER SCREENING MARKET SIZE, BY BREAST, 2018-2024 (USD MILLION)
TABLE 310. CANADA SINGLE CANCER SCREENING MARKET SIZE, BY BREAST, 2025-2030 (USD MILLION)
TABLE 311. CANADA SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 312. CANADA SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 313. CANADA SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 314. CANADA SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 315. CANADA SINGLE CANCER SCREENING MARKET SIZE, BY CERVICAL, 2018-2024 (USD MILLION)
TABLE 316. CANADA SINGLE CANCER SCREENING MARKET SIZE, BY CERVICAL, 2025-2030 (USD MILLION)
TABLE 317. CANADA SINGLE CANCER SCREENING MARKET SIZE, BY COLORECTAL, 2018-2024 (USD MILLION)
TABLE 318. CANADA SINGLE CANCER SCREENING MARKET SIZE, BY COLORECTAL, 2025-2030 (USD MILLION)
TABLE 319. CANADA SINGLE CANCER SCREENING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
TABLE 320. CANADA SINGLE CANCER SCREENING MARKET SIZE, BY ENDOSCOPY, 2025-2030 (USD MILLION)
TABLE 321. CANADA SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 322. CANADA SINGLE CANCER SCREENING MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 323. CANADA SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 324. CANADA SINGLE CANCER SCREENING MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 325. CANADA SINGLE CANCER SCREENING MARKET SIZE, BY LUNG, 2018-2024 (USD MILLION)
TABLE 326. CANADA SINGLE CANCER SCREENING MARKET SIZE, B

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Single Cancer Screening market report include:
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • Hologic, Inc.
  • QIAGEN N.V.
  • Myriad Genetics, Inc.
  • Exact Sciences Corporation
  • Becton Dickinson and Company

Related Topics

Related Reports

Colorectal Cancer Screening & Diagnostic Market - Global Forecast 2025-2030 - Product Image

Colorectal Cancer Screening & Diagnostic Market - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Oral Cancer Screening Device Market - Global Forecast 2025-2030 - Product Image

Oral Cancer Screening Device Market - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Colorectal Cancer Screening Market Report 2025 - Product Image

Colorectal Cancer Screening Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Cervical Cancer Screening, Diagnostics, and Pre-cancerous Dysplasia Lesion Treatment Market by Type (Cervical Cancer Screening, Cervical Cancer Diagnostics, Pre-cancerous Lesion Treatment), Region, and Segment Forecasts, 2025 - 2035 - Product Image

Cervical Cancer Screening, Diagnostics, and Pre-cancerous Dysplasia Lesion Treatment Market by Type (Cervical Cancer Screening, Cervical Cancer Diagnostics, Pre-cancerous Lesion Treatment), Region, and Segment Forecasts, 2025 - 2035

  • Report
  • 150 Pages
  • Global
From
Lung Cancer Screening Software - Global Strategic Business Report - Product Image

Lung Cancer Screening Software - Global Strategic Business Report

  • Report
  • 98 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.